Effect of treatment with recombinant bovine somatotropin on responses to superovulatory treatment in swamp buffalo (Bubalus bubalis).
The objective of this study was to determine the effect of treatment with recombinant bovine somatotropin (rBST) on the response to superovulatory treatment in swamp buffalo. Estrous cycles of 16 buffalo cows were synchronized by intravaginal administration of progesterone and estradiol benzoate, and the cows were then randomly divided into 2 groups. The rBST-treated group received 250 mg of a sustained-release formula of rBST on Day 4 after progesterone implantation, whereas the control group did not receive rBST. Both groups were then given a superovulatory regimen of twice daily injections of FSH for 3.5 d (total dose of 260 mg, i.m.), between Days 9 and 11 after administration of progesterone. The cows were bred naturally 1 d after the last FSH injection, then 6 d after breeding they were slaughtered, and their reproductive tracts were removed. The numbers of corpora lutea (CL) and follicles were recorded, and embryos were flushed out of the uterine horns. There were no significant differences between the rBST-treated and control cows for the mean numbers (+/- SEM) of CL (6.0 +/- 2.2 vs 4.3 +/- 1.1), follicles (15.9 +/- 4.1 vs 19.8 +/- 2.9), or total embryos recovered per collection (4.5 +/- 1.6 vs 2.3 +/- 1.0). However, there were significant differences between rBST-treated and control cows for the numbers of transferable embryos per collection (3.0 +/- 1.0 vs 0.8 +/- 0.3; P < or = 0.05) and the overall proportion of transferable embryos (75 vs 33%; P < or = 0.01). The results of this study show that pretreatment of swamp buffalo with rBST significantly increases the production of transferable embryos in response to superovulation.
Songsasen
N
N
Artificial Insemination Division, Department of Livestock Development, Pathumthani, Thailand.
Yiengvisavakul
V
V
Buntaracha
B
B
Pharee
S
S
Apimeteetumrong
M
M
Sukwongs
Y
Y
D000818:Animals; D002020:Buffaloes; D002417:Cattle; D003338:Corpus Luteum / Q000166:cytology / Q000187:drug effects; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D013006:Growth Hormone / Q000627:therapeutic use*; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D013480:Superovulation / Q000187:drug effects*
D011374:Progesterone; D004958:Estradiol; D013006:Growth Hormone